Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
Christopher T CampbellLucas DiazBrian KellyPublished in: The Annals of pharmacotherapy (2020)
Bivalirudin dosing in ECMO and VAD patients is consistent with dosing seen in previous reports but may be higher in VAD patients. Comparative studies between heparin and bivalirudin are necessary to compare cost-effective outcomes for pediatric patients.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- percutaneous coronary intervention
- peritoneal dialysis
- emergency department
- atrial fibrillation
- acute coronary syndrome
- coronary artery disease
- acute respiratory distress syndrome
- metabolic syndrome
- intensive care unit
- weight loss
- skeletal muscle
- growth factor
- adverse drug
- glycemic control